| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/2003 | WO2002053755A3 Regulation of human otu-like cysteine protease |
| 02/27/2003 | WO2002053716A3 Regulation of human ornithine decarboxylase |
| 02/27/2003 | WO2002049577A3 Analogues of thiocoraline and be-22179 |
| 02/27/2003 | WO2002048375A3 Purified active hcv ns2/3 protease |
| 02/27/2003 | WO2002046440A3 Processes and vectors for producing transgenic plants |
| 02/27/2003 | WO2002046438A3 Processes and vectors for producing transgenic plants |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002042733A3 Method for analyzing mass spectra |
| 02/27/2003 | WO2002042451A3 Aspergillus fumigatus cofilin |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002040637A3 Antisense modulation of pi3k p85 expression |
| 02/27/2003 | WO2002038747A3 Human adenylate cyclase |
| 02/27/2003 | WO2002036828A3 COMPOSITIONS AND SYSTEMS FOR IDENTIFYING AND COMPARING EXPRESSED GENES (mRNAs) IN EUKARYOTIC ORGANISMS |
| 02/27/2003 | WO2002034950A3 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 02/27/2003 | WO2002032378A3 Fusion cells and cytokine compositions for treatment of disease |
| 02/27/2003 | WO2002031161A3 Regulation of human phospholipase-like enzyme |
| 02/27/2003 | WO2002031156A3 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/27/2003 | WO2002030471A3 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 02/27/2003 | WO2002029047A3 Regulation of human gpcr-like protein |
| 02/27/2003 | WO2002029000A3 Methods of minimizing immunological rejection of a nuclear transfer fetus |
| 02/27/2003 | WO2002026945A3 Regulation of human aminotransferase-like enzyme |
| 02/27/2003 | WO2002022810A3 Combinatorial screening of mixed populations of organisms |
| 02/27/2003 | WO2002020767A3 G-csf analog compositions and methods |
| 02/27/2003 | WO2002020761A3 Human vomeronasal receptor-4 |
| 02/27/2003 | WO2002018607A3 Transgenic plants containing molecular decoys that alter protein content therein |
| 02/27/2003 | WO2002018590A3 Identification of activated receptors and ion channels |
| 02/27/2003 | WO2002018555A3 Human kinase proteins and polynucleotides encoding the same |
| 02/27/2003 | WO2002017711A3 Therapeutics and diagnostics based on a novel signal transduction system in platelets |
| 02/27/2003 | WO2002016948A3 High throughput method and kit |
| 02/27/2003 | WO2002016621A3 Constitutive promoter from arabidopsis |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002014555A3 Single-labeled oligonucleotide probes |
| 02/27/2003 | WO2002014553A3 A molecular vector identification system |
| 02/27/2003 | WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/27/2003 | WO2002010352A3 Production of human monoclonal antibodies |
| 02/27/2003 | WO2002008436A3 Mini-adenoviral vector system for vaccination |
| 02/27/2003 | WO2002008407A9 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 02/27/2003 | WO2002008269A3 A cytochrome p450 enzyme associated with the synthesis of δ12-epoxy groups in fatty acids of plants |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002004605A3 Stimulation of cellular regeneration and differentiation in the inner ear |
| 02/27/2003 | WO2002004022A8 High fidelity polymerases and uses thereof |
| 02/27/2003 | WO2002003789A3 Transgenic mice containing targeted gpcr gene disruptions |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002001950A3 Transgenic mice containing targeted gene disruptions |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098481A3 Renal regulatory elements and methods of use thereof |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001090160A3 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| 02/27/2003 | WO2001085924A3 MODULATION OF η-SECRETASE ACTIVITY |
| 02/27/2003 | WO2001079558A8 High-throughput screening of expressed dna libraries in filamentous fungi |
| 02/27/2003 | WO2001075164A3 Rna sequence-specific mediators of rna interference |
| 02/27/2003 | WO2001071356A3 Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof |
| 02/27/2003 | US20030041357 Nucleotide sequences coding polypeptide for use in the generation of disease, insect and herbicide resistant plants |
| 02/27/2003 | US20030041356 Methods for modifying flowering phenotypes |
| 02/27/2003 | US20030041355 Method of humanizing plant cDNA |
| 02/27/2003 | US20030041354 Transgenic plants |
| 02/27/2003 | US20030041353 Expression vector for use in the expression of heterologous proteins in plants; bioremediation; generation of disease resistant plants |
| 02/27/2003 | US20030041352 Arabitol or ribitol as positive selectable markers |
| 02/27/2003 | US20030041351 Cotton plants with improved cotton fiber characteristics and method for producing cotton fibers from these cotton plants |
| 02/27/2003 | US20030041350 Hypoallergenic transgenic soybeans |
| 02/27/2003 | US20030041349 Insect viruses and their uses in protecting plants |
| 02/27/2003 | US20030041348 Nucleotidesequences coding polypeptide for use in the generaton of disease resistant plants |
| 02/27/2003 | US20030041347 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 02/27/2003 | US20030041346 Cytochrome P450 monooxygenases |
| 02/27/2003 | US20030041345 Nucleotide sequences coding enzymatic polypeptide for use in the propagation of plants |
| 02/27/2003 | US20030041344 Receptor kinase, BIN1 |
| 02/27/2003 | US20030041343 Cell cycle polynucleotides, polyeptides and uses thereof |
| 02/27/2003 | US20030041342 Nucleotide sequences for use in the propagation of agricultural crops |
| 02/27/2003 | US20030041341 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in DNA encoding 4E-BP1 |
| 02/27/2003 | US20030041340 Animal model for fatty acid amide-related neurobehaviors |
| 02/27/2003 | US20030041337 Animal model for use in the diagnosis and treatment of diabetic phenotype |
| 02/27/2003 | US20030040621 Chromatography material and a method using same |
| 02/27/2003 | US20030040620 Method of producing a DNA library using positional amplification |
| 02/27/2003 | US20030040619 Generation of disease pest resistant plants; obtain plant, transform with vector coding toxin, recover transformed plant, monitor for resistance to biological pest |
| 02/27/2003 | US20030040614 Generation of enzyme containing polypeptides; obtain nucleotide sequences, mutagenize, express nucleotide sequences, recover mutant enzymatic polypeptides |
| 02/27/2003 | US20030040613 Structurally modified molecular decoys for the manipulation of cellular or viral replication and other uses relating thereto |
| 02/27/2003 | US20030040611 Nucleotide sequences coding polypeptide for use in the treatment of nervous system and bone disorders |
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040606 Reducing immunogenicities of immunoglobulins by framework-patching |
| 02/27/2003 | US20030040605 Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
| 02/27/2003 | US20030040603 Purified mammalian CTLA-8 antigens and related reagents |
| 02/27/2003 | US20030040500 Replication incompetent herpes virus vectors |
| 02/27/2003 | US20030040499 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 02/27/2003 | US20030040498 Contacting the tumor cell with a replicon such that the replicon is taken up into tumor cell and tumor cell is killed |
| 02/27/2003 | US20030040497 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/27/2003 | US20030040496 Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehicles |
| 02/27/2003 | US20030040495 Collecting tissue; determining amount of mitochondrial DNA damage in tissue; comparing the amount of mitochondrial DNA damage in tissue of interest to the amount of mitochondrial DNA damage in tissue of interest from a control |
| 02/27/2003 | US20030040476 EAG gene |
| 02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040470 For therapy of hypercholesterolemia, viral infection |
| 02/27/2003 | US20030040466 Identifying peptide of interest; preparing peptide to be coupled to a sensor; preparing sensor to be coupled to peptide; coupling peptide to sensor; quantifying signal output from sensor; exposing sensor ligands; quantifying signal |
| 02/27/2003 | US20030040465 Neuregulins as modulators of cellular communication |
| 02/27/2003 | US20030040111 Differentiated cells suitable for human therapy |
| 02/27/2003 | US20030040110 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 02/27/2003 | US20030040103 Fermentation process for the preparation of L-amino acids using strains of the family enterobacteriaceae |
| 02/27/2003 | US20030040102 Feedback-regulated expression system and uses thereof |
| 02/27/2003 | US20030040101 Transgenic cell for in the generation and propagation of viral expression vectors |
| 02/27/2003 | US20030040100 Cell for the propagation of adenoviral vectors |
| 02/27/2003 | US20030040099 Nucleotide sequences coding polypeptide for use the generating vaccine for treatment and prevention of viral diseases |
| 02/27/2003 | US20030040098 Glutaminase, glutaminase gene, novel recombinant DNA, and process for manufacturing glutaminase |